SB202190 is a highly selective, potent and cell-permeable inhibitor of p38 MAP kinases with IC50 values of 50 nM and 100 nM for p38α and p38β, respectively.

Goals and Objectives: (1) Increase awareness of and access to health care and risk prevention among underserved children and families in partnership with other ...

SB202190. Synonyms: FHPI. Catalog No.S1077 Purity: 99.99%. SB202190 is a potent p38 MAPK inhibitor targeting p38α/β with IC50 of 50 nM/100 nM in cell-free ...

View and buy high purity SB202190 (FHPI) from AOBIOUS, the leading supplier of life science reagents.

This is a laboratory product for research use only. Not for personal consumption. It will not be effective and is dangerous for personal use.

SB202190 (FHPI) is a potent p38 MAPK inhibitor targeting p38?/? with IC50 of 50 nM/100 nM in cell-free assays, sometimes used instead of SB 203580 to ...

SB 202190 (FHPI) is a selective and cell-permeable inhibitor of p38 MAPK (IC50s: 50/100 nM for p38α/p38β).

However, FHPI inhibited HCMV DNA replication and late gene expression. The inhibitory effect of FHPI was reversible, as demonstrated by the induction of HCMV ...

SB202190 (FHPI) · SB202190 (FHPI) [orb1102044]. Purity: > 98%. CAS Number: [152121-30-7]. MW: 331.34 · SB202190 [orb1713702]. Purity: ≥98% (TLC). CAS Number:.